Circulating Metabolites May Illustrate Relationship of Alcohol Consumption with Cardiovascular Disease

Background: Metabolite signatures of long-term alcohol consumption are lacking. To better understand the molecular basis linking alcohol drinking and cardiovascular disease (CVD), we investigated circulating metabolites associated with long-term alcohol consumption and examined whether these metabolites were associated with incident CVD. Methods: Cumulative average alcohol consumption (g/day) was derived from the total consumption of beer, wine and liquor on average of 19 years in 2,428 Framingham Heart Study Offspring participants (mean age 56 years, 52% women). We used linear mixed models to investigate the associations of alcohol consumption with 211 log-transformed plasma metabolites, adjusting for age, sex, batch, smoking, diet, physical activity, BMI, and familial relationship. Cox models were used to test the association of alcohol-related metabolite scores with fatal and nonfatal incident CVD (myocardial infarction, coronary heart disease, stroke, and heart failure). Results: We identified 60 metabolites associated with cumulative average alcohol consumption (p<0.05/211=0.00024). For example, one g/day increase of alcohol consumption was associated with higher levels of cholesteryl esters (e.g., CE 16:1, beta=0.023, SE=0.002, p=6.3e-45) and phosphatidylcholine (e.g., PC 32:1, beta=0.021, SE=0.002, p=3.1e-38). Survival analysis identified that 10 alcohol-associated metabolites were also associated with a differential CVD risk after adjusting for age, sex, and batch. Further, we built two alcohol consumption weighted metabolite scores using these 10 metabolites and showed that, with adjustment age, sex, batch, and common CVD risk factors, the two scores had comparable but opposite associations with incident CVD, hazard ratio 1.11(95% CI=[1.02, 1.21], p=0.02) vs 0.88 (95% CI=[0.78, 0.98], p=0.02). Summary: We identified 60 long-term alcohol consumption-associated metabolites. The association analysis with incident CVD suggests a complex metabolic basis between alcohol consumption and CVD.

[1]  J. Ärnlöv,et al.  Large‐Scale Metabolomics and the Incidence of Cardiovascular Disease , 2023, Journal of the American Heart Association.

[2]  P. White,et al.  Branched-chain amino acids in cardiovascular disease , 2022, Nature Reviews Cardiology.

[3]  J. Weitz,et al.  Plasma triacylglycerols are biomarkers of β-cell function in mice and humans , 2021, Molecular metabolism.

[4]  Shih-Jen Hwang,et al.  Associations of Alcohol Consumption with Cardiovascular Disease-Related Proteomic Biomarkers: The Framingham Heart Study. , 2021, The Journal of nutrition.

[5]  S. Horvath,et al.  Higher diet quality relates to decelerated epigenetic aging. , 2021, The American journal of clinical nutrition.

[6]  J. Xia,et al.  MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights , 2021, Nucleic Acids Res..

[7]  G. Davey Smith,et al.  Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study , 2020, PLoS medicine.

[8]  Q. Lei,et al.  Metabolite sensing and signaling in cancer , 2020, The Journal of Biological Chemistry.

[9]  U. Nöthlings,et al.  The Association between Alcohol Consumption and Serum Metabolites and the Modifying Effect of Smoking , 2019, Nutrients.

[10]  J. Rehm,et al.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. , 2019, The American journal of gastroenterology.

[11]  F. Parveen,et al.  An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases , 2019, International journal of molecular sciences.

[12]  M. Kivimäki,et al.  Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study , 2018, British Medical Journal.

[13]  Daniel Levy,et al.  Protein Biomarkers of Cardiovascular Disease and Mortality in the Community , 2018, Journal of the American Heart Association.

[14]  E. Riboli,et al.  Circulating Metabolites Associated with Alcohol Intake in the European Prospective Investigation into Cancer and Nutrition Cohort , 2018, Nutrients.

[15]  R. Marioni,et al.  A DNA methylation biomarker of alcohol consumption , 2016, Molecular Psychiatry.

[16]  E. Rimm,et al.  Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose–Response Meta-Analysis , 2016, Circulation.

[17]  Ming-Huei Chen,et al.  Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes , 2016, PloS one.

[18]  Ramachandran S Vasan,et al.  Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. , 2015, International journal of epidemiology.

[19]  Susan Cheng,et al.  Long‐term Cardiovascular Risks Associated With an Elevated Heart Rate: The Framingham Heart Study , 2014, Journal of the American Heart Association.

[20]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[21]  T. Spector,et al.  Alcohol-induced metabolomic differences in humans , 2013, Translational Psychiatry.

[22]  W. R. Wikoff,et al.  Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo , 2013, Translational Psychiatry.

[23]  C. Gieger,et al.  Human metabolic individuality in biomedical and pharmaceutical research , 2011, Nature.

[24]  S. Carr,et al.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. , 2011, The Journal of clinical investigation.

[25]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[26]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[27]  S. Ramsey,et al.  Alcohol use of diabetes patients: the need for assessment and intervention , 2013, Acta Diabetologica.

[28]  M. Lever,et al.  The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. , 2010, Clinical biochemistry.

[29]  Shobha Ghosh,et al.  Macrophage cholesteryl ester mobilization and atherosclerosis. , 2010, Vascular pharmacology.

[30]  J. Wagner,et al.  Pharmacokinetics of ethanol after oral administration in the fasting state , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[31]  L Nadeau,et al.  Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. , 2000, Addiction.

[32]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[34]  C. Lieber,et al.  Effects of ethanol on lipid metabolism. , 1979, Journal of lipid research.

[35]  W. Kannel,et al.  The Framingham Offspring Study. Design and preliminary data. , 1975, Preventive medicine.

[36]  P. Seifert,et al.  Alcohol Metabolism , 2020, Where Does All That Food Go?.